nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—DNMT1—type 2 diabetes mellitus	0.279	1	CbGaD
Procainamide—Probenecid—Tolbutamide—type 2 diabetes mellitus	0.135	0.34	CrCrCtD
Procainamide—Probenecid—Chlorpropamide—type 2 diabetes mellitus	0.123	0.311	CrCrCtD
Procainamide—BCHE—Ramipril—type 2 diabetes mellitus	0.0378	0.298	CbGbCtD
Procainamide—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.0368	0.093	CrCrCtD
Procainamide—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.0349	0.0881	CrCrCtD
Procainamide—Sulfacetamide—Tolbutamide—type 2 diabetes mellitus	0.0349	0.0881	CrCrCtD
Procainamide—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.0319	0.0806	CrCrCtD
Procainamide—SLC22A3—Metformin—type 2 diabetes mellitus	0.0238	0.188	CbGbCtD
Procainamide—SLC22A2—Metformin—type 2 diabetes mellitus	0.0141	0.111	CbGbCtD
Procainamide—SLC22A1—Metformin—type 2 diabetes mellitus	0.0122	0.0965	CbGbCtD
Procainamide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0114	0.0899	CbGbCtD
Procainamide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0105	0.0829	CbGbCtD
Procainamide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00862	0.0681	CbGbCtD
Procainamide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00826	0.0653	CbGbCtD
Procainamide—SCN11A—peripheral nervous system—type 2 diabetes mellitus	0.00299	0.107	CbGeAlD
Procainamide—SCN11A—nerve—type 2 diabetes mellitus	0.00233	0.0835	CbGeAlD
Procainamide—SCN8A—peripheral nervous system—type 2 diabetes mellitus	0.00226	0.0812	CbGeAlD
Procainamide—SCN8A—nerve—type 2 diabetes mellitus	0.00176	0.0633	CbGeAlD
Procainamide—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00151	0.0543	CbGeAlD
Procainamide—SCN10A—nerve—type 2 diabetes mellitus	0.00118	0.0424	CbGeAlD
Procainamide—Sunitinib—INSR—type 2 diabetes mellitus	0.000705	0.269	CrCbGaD
Procainamide—SCN7A—cardiovascular system—type 2 diabetes mellitus	0.000693	0.0249	CbGeAlD
Procainamide—DNMT1—retina—type 2 diabetes mellitus	0.00063	0.0226	CbGeAlD
Procainamide—SCN7A—adipose tissue—type 2 diabetes mellitus	0.000611	0.0219	CbGeAlD
Procainamide—SCN9A—nephron tubule—type 2 diabetes mellitus	0.000605	0.0217	CbGeAlD
Procainamide—ACHE—islet of Langerhans—type 2 diabetes mellitus	0.000598	0.0215	CbGeAlD
Procainamide—DNMT1—cardiovascular system—type 2 diabetes mellitus	0.000533	0.0191	CbGeAlD
Procainamide—DNMT1—cortex of kidney—type 2 diabetes mellitus	0.000508	0.0182	CbGeAlD
Procainamide—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000495	0.0178	CbGeAlD
Procainamide—SCN9A—adipose tissue—type 2 diabetes mellitus	0.000479	0.0172	CbGeAlD
Procainamide—Sunitinib—PRKAA1—type 2 diabetes mellitus	0.000476	0.182	CrCbGaD
Procainamide—SCN4A—kidney—type 2 diabetes mellitus	0.000474	0.017	CbGeAlD
Procainamide—DNMT1—adipose tissue—type 2 diabetes mellitus	0.00047	0.0169	CbGeAlD
Procainamide—SCN10A—nephron tubule—type 2 diabetes mellitus	0.00046	0.0165	CbGeAlD
Procainamide—SLC22A2—kidney—type 2 diabetes mellitus	0.000435	0.0156	CbGeAlD
Procainamide—SCN7A—liver—type 2 diabetes mellitus	0.000429	0.0154	CbGeAlD
Procainamide—Cinchocaine—CALM1—type 2 diabetes mellitus	0.000428	0.164	CrCbGaD
Procainamide—SCN4A—adipose tissue—type 2 diabetes mellitus	0.000427	0.0153	CbGeAlD
Procainamide—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000424	0.0152	CbGeAlD
Procainamide—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.000409	0.0147	CbGeAlD
Procainamide—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000376	0.0135	CbGeAlD
Procainamide—SCN3A—kidney—type 2 diabetes mellitus	0.000369	0.0132	CbGeAlD
Procainamide—SLC22A4—nephron tubule—type 2 diabetes mellitus	0.000367	0.0132	CbGeAlD
Procainamide—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.000359	0.0129	CbGeAlD
Procainamide—SCN3A—adipose tissue—type 2 diabetes mellitus	0.000332	0.0119	CbGeAlD
Procainamide—DNMT1—liver—type 2 diabetes mellitus	0.000329	0.0118	CbGeAlD
Procainamide—SLC22A4—kidney—type 2 diabetes mellitus	0.000323	0.0116	CbGeAlD
Procainamide—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.00032	0.0115	CbGeAlD
Procainamide—SLC22A4—cortex of kidney—type 2 diabetes mellitus	0.000314	0.0113	CbGeAlD
Procainamide—SLC22A1—kidney—type 2 diabetes mellitus	0.000307	0.011	CbGeAlD
Procainamide—SLC22A3—kidney—type 2 diabetes mellitus	0.000294	0.0105	CbGeAlD
Procainamide—SLC22A4—adipose tissue—type 2 diabetes mellitus	0.000291	0.0104	CbGeAlD
Procainamide—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000277	0.00994	CbGeAlD
Procainamide—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000265	0.0095	CbGeAlD
Procainamide—SLC22A5—retina—type 2 diabetes mellitus	0.000258	0.00926	CbGeAlD
Procainamide—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000243	0.00873	CbGeAlD
Procainamide—BCHE—nephron tubule—type 2 diabetes mellitus	0.000237	0.0085	CbGeAlD
Procainamide—SLC22A5—kidney—type 2 diabetes mellitus	0.000214	0.00767	CbGeAlD
Procainamide—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000213	0.00763	CbGeAlD
Procainamide—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000208	0.00747	CbGeAlD
Procainamide—SLC22A1—liver—type 2 diabetes mellitus	0.000194	0.00697	CbGeAlD
Procainamide—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000193	0.00691	CbGeAlD
Procainamide—BCHE—adipose tissue—type 2 diabetes mellitus	0.000188	0.00673	CbGeAlD
Procainamide—SLC22A3—liver—type 2 diabetes mellitus	0.000186	0.00667	CbGeAlD
Procainamide—Moclobemide—CYP1A2—type 2 diabetes mellitus	0.00017	0.065	CrCbGaD
Procainamide—Lidocaine—EGFR—type 2 diabetes mellitus	0.000158	0.0603	CrCbGaD
Procainamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000143	0.00157	CcSEcCtD
Procainamide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000143	0.00156	CcSEcCtD
Procainamide—Renal failure—Losartan—type 2 diabetes mellitus	0.000142	0.00155	CcSEcCtD
Procainamide—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000142	0.00155	CcSEcCtD
Procainamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000142	0.00155	CcSEcCtD
Procainamide—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00154	CcSEcCtD
Procainamide—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000141	0.00154	CcSEcCtD
Procainamide—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00014	0.00154	CcSEcCtD
Procainamide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.00153	CcSEcCtD
Procainamide—Confusional state—Glyburide—type 2 diabetes mellitus	0.000139	0.00152	CcSEcCtD
Procainamide—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000139	0.00152	CcSEcCtD
Procainamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000138	0.00151	CcSEcCtD
Procainamide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000138	0.00151	CcSEcCtD
Procainamide—CYP2D6—kidney—type 2 diabetes mellitus	0.000138	0.00495	CbGeAlD
Procainamide—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000138	0.00151	CcSEcCtD
Procainamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000138	0.00151	CcSEcCtD
Procainamide—Malaise—Gliclazide—type 2 diabetes mellitus	0.000137	0.0015	CcSEcCtD
Procainamide—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000137	0.0015	CcSEcCtD
Procainamide—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000137	0.0015	CcSEcCtD
Procainamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000137	0.00149	CcSEcCtD
Procainamide—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000137	0.00149	CcSEcCtD
Procainamide—Shock—Glyburide—type 2 diabetes mellitus	0.000136	0.00149	CcSEcCtD
Procainamide—Probenecid—ABCC2—type 2 diabetes mellitus	0.000136	0.0519	CrCbGaD
Procainamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000136	0.00148	CcSEcCtD
Procainamide—Flushing—Metformin—type 2 diabetes mellitus	0.000136	0.00148	CcSEcCtD
Procainamide—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000136	0.00148	CcSEcCtD
Procainamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000135	0.00148	CcSEcCtD
Procainamide—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000135	0.00148	CcSEcCtD
Procainamide—SLC22A5—liver—type 2 diabetes mellitus	0.000135	0.00485	CbGeAlD
Procainamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000135	0.00148	CcSEcCtD
Procainamide—Aminohippurate—ABCC2—type 2 diabetes mellitus	0.000134	0.0512	CrCbGaD
Procainamide—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000133	0.00146	CcSEcCtD
Procainamide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000133	0.00146	CcSEcCtD
Procainamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000133	0.00145	CcSEcCtD
Procainamide—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000132	0.00145	CcSEcCtD
Procainamide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000132	0.00145	CcSEcCtD
Procainamide—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00144	CcSEcCtD
Procainamide—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000132	0.00144	CcSEcCtD
Procainamide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000132	0.00144	CcSEcCtD
Procainamide—BCHE—liver—type 2 diabetes mellitus	0.000132	0.00472	CbGeAlD
Procainamide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00144	CcSEcCtD
Procainamide—Chills—Metformin—type 2 diabetes mellitus	0.000131	0.00143	CcSEcCtD
Procainamide—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00013	0.00142	CcSEcCtD
Procainamide—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000129	0.00142	CcSEcCtD
Procainamide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000129	0.00142	CcSEcCtD
Procainamide—Hypotension—Glyburide—type 2 diabetes mellitus	0.000129	0.00141	CcSEcCtD
Procainamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000129	0.00141	CcSEcCtD
Procainamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000129	0.00141	CcSEcCtD
Procainamide—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000128	0.0014	CcSEcCtD
Procainamide—Flushing—Irbesartan—type 2 diabetes mellitus	0.000128	0.0014	CcSEcCtD
Procainamide—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000128	0.0014	CcSEcCtD
Procainamide—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000128	0.0014	CcSEcCtD
Procainamide—Angioedema—Valsartan—type 2 diabetes mellitus	0.000128	0.0014	CcSEcCtD
Procainamide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000127	0.00139	CcSEcCtD
Procainamide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000127	0.00139	CcSEcCtD
Procainamide—Angioedema—Orlistat—type 2 diabetes mellitus	0.000126	0.00138	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000126	0.00138	CcSEcCtD
Procainamide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000125	0.00137	CcSEcCtD
Procainamide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000125	0.00136	CcSEcCtD
Procainamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000125	0.00136	CcSEcCtD
Procainamide—Malaise—Orlistat—type 2 diabetes mellitus	0.000124	0.00136	CcSEcCtD
Procainamide—Chills—Irbesartan—type 2 diabetes mellitus	0.000124	0.00135	CcSEcCtD
Procainamide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000124	0.00135	CcSEcCtD
Procainamide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000123	0.00135	CcSEcCtD
Procainamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000123	0.00135	CcSEcCtD
Procainamide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000123	0.00135	CcSEcCtD
Procainamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000123	0.00134	CcSEcCtD
Procainamide—Renal failure—Ramipril—type 2 diabetes mellitus	0.000122	0.00133	CcSEcCtD
Procainamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000122	0.00133	CcSEcCtD
Procainamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000122	0.00133	CcSEcCtD
Procainamide—Flushing—Losartan—type 2 diabetes mellitus	0.00012	0.00132	CcSEcCtD
Procainamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00131	CcSEcCtD
Procainamide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000119	0.0013	CcSEcCtD
Procainamide—Myalgia—Valsartan—type 2 diabetes mellitus	0.000119	0.0013	CcSEcCtD
Procainamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000119	0.0013	CcSEcCtD
Procainamide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000119	0.0013	CcSEcCtD
Procainamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000118	0.00129	CcSEcCtD
Procainamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000118	0.00129	CcSEcCtD
Procainamide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000118	0.00129	CcSEcCtD
Procainamide—Myalgia—Orlistat—type 2 diabetes mellitus	0.000118	0.00128	CcSEcCtD
Procainamide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000116	0.00127	CcSEcCtD
Procainamide—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000116	0.00127	CcSEcCtD
Procainamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000116	0.00126	CcSEcCtD
Procainamide—Malaise—Metformin—type 2 diabetes mellitus	0.000115	0.00125	CcSEcCtD
Procainamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000115	0.00125	CcSEcCtD
Procainamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00125	CcSEcCtD
Procainamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000114	0.00125	CcSEcCtD
Procainamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000114	0.00125	CcSEcCtD
Procainamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000114	0.00124	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000113	0.00124	CcSEcCtD
Procainamide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000113	0.00124	CcSEcCtD
Procainamide—Shock—Valsartan—type 2 diabetes mellitus	0.000112	0.00123	CcSEcCtD
Procainamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000112	0.00122	CcSEcCtD
Procainamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.00122	CcSEcCtD
Procainamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000111	0.00121	CcSEcCtD
Procainamide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000111	0.00121	CcSEcCtD
Procainamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00011	0.00121	CcSEcCtD
Procainamide—Urticaria—Glyburide—type 2 diabetes mellitus	0.00011	0.0012	CcSEcCtD
Procainamide—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00011	0.0012	CcSEcCtD
Procainamide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000109	0.00119	CcSEcCtD
Procainamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000109	0.00119	CcSEcCtD
Procainamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00119	CcSEcCtD
Procainamide—Myalgia—Metformin—type 2 diabetes mellitus	0.000108	0.00118	CcSEcCtD
Procainamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000108	0.00118	CcSEcCtD
Procainamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000107	0.00117	CcSEcCtD
Procainamide—Sunitinib—ABCC2—type 2 diabetes mellitus	0.000107	0.0408	CrCbGaD
Procainamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000107	0.00117	CcSEcCtD
Procainamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Procainamide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Procainamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000106	0.00116	CcSEcCtD
Procainamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000105	0.00115	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000104	0.00114	CcSEcCtD
Procainamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00113	CcSEcCtD
Procainamide—Flushing—Ramipril—type 2 diabetes mellitus	0.000103	0.00113	CcSEcCtD
Procainamide—Angioedema—Losartan—type 2 diabetes mellitus	0.000103	0.00113	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000103	0.00112	CcSEcCtD
Procainamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000102	0.00112	CcSEcCtD
Procainamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000102	0.00112	CcSEcCtD
Procainamide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000102	0.00112	CcSEcCtD
Procainamide—Shock—Metformin—type 2 diabetes mellitus	0.000102	0.00112	CcSEcCtD
Procainamide—Malaise—Losartan—type 2 diabetes mellitus	0.000102	0.00111	CcSEcCtD
Procainamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000102	0.00111	CcSEcCtD
Procainamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000102	0.00111	CcSEcCtD
Procainamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000101	0.00111	CcSEcCtD
Procainamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000101	0.0011	CcSEcCtD
Procainamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0001	0.00109	CcSEcCtD
Procainamide—Nausea—Glimepiride—type 2 diabetes mellitus	9.95e-05	0.00109	CcSEcCtD
Procainamide—Nausea—Sitagliptin—type 2 diabetes mellitus	9.92e-05	0.00108	CcSEcCtD
Procainamide—Asthenia—Glyburide—type 2 diabetes mellitus	9.92e-05	0.00108	CcSEcCtD
Procainamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.91e-05	0.00108	CcSEcCtD
Procainamide—Anorexia—Metformin—type 2 diabetes mellitus	9.9e-05	0.00108	CcSEcCtD
Procainamide—Urticaria—Gliclazide—type 2 diabetes mellitus	9.86e-05	0.00108	CcSEcCtD
Procainamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.00107	CcSEcCtD
Procainamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.00107	CcSEcCtD
Procainamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.79e-05	0.00107	CcSEcCtD
Procainamide—Pruritus—Glyburide—type 2 diabetes mellitus	9.78e-05	0.00107	CcSEcCtD
Procainamide—Hypotension—Metformin—type 2 diabetes mellitus	9.7e-05	0.00106	CcSEcCtD
Procainamide—Shock—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.00105	CcSEcCtD
Procainamide—Arthralgia—Losartan—type 2 diabetes mellitus	9.62e-05	0.00105	CcSEcCtD
Procainamide—Myalgia—Losartan—type 2 diabetes mellitus	9.62e-05	0.00105	CcSEcCtD
Procainamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.61e-05	0.00105	CcSEcCtD
Procainamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.00105	CcSEcCtD
Procainamide—Discomfort—Losartan—type 2 diabetes mellitus	9.5e-05	0.00104	CcSEcCtD
Procainamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.49e-05	0.00104	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.46e-05	0.00103	CcSEcCtD
Procainamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.46e-05	0.00103	CcSEcCtD
Procainamide—Anorexia—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.00102	CcSEcCtD
Procainamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.32e-05	0.00102	CcSEcCtD
Procainamide—Confusional state—Losartan—type 2 diabetes mellitus	9.3e-05	0.00102	CcSEcCtD
Procainamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.28e-05	0.00102	CcSEcCtD
Procainamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.21e-05	0.00101	CcSEcCtD
Procainamide—Hypotension—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.001	CcSEcCtD
Procainamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.14e-05	0.001	CcSEcCtD
Procainamide—Shock—Losartan—type 2 diabetes mellitus	9.07e-05	0.000992	CcSEcCtD
Procainamide—Urticaria—Valsartan—type 2 diabetes mellitus	9.06e-05	0.00099	CcSEcCtD
Procainamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000987	CcSEcCtD
Procainamide—Decreased appetite—Metformin—type 2 diabetes mellitus	9.03e-05	0.000987	CcSEcCtD
Procainamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000985	CcSEcCtD
Procainamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000983	CcSEcCtD
Procainamide—Nausea—Bromocriptine—type 2 diabetes mellitus	8.98e-05	0.000982	CcSEcCtD
Procainamide—Urticaria—Orlistat—type 2 diabetes mellitus	8.95e-05	0.000979	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000976	CcSEcCtD
Procainamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.91e-05	0.000974	CcSEcCtD
Procainamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.91e-05	0.000974	CcSEcCtD
Procainamide—Asthenia—Gliclazide—type 2 diabetes mellitus	8.9e-05	0.000974	CcSEcCtD
Procainamide—Angioedema—Ramipril—type 2 diabetes mellitus	8.85e-05	0.000968	CcSEcCtD
Procainamide—Anorexia—Losartan—type 2 diabetes mellitus	8.79e-05	0.000961	CcSEcCtD
Procainamide—Vomiting—Glyburide—type 2 diabetes mellitus	8.79e-05	0.000961	CcSEcCtD
Procainamide—Pruritus—Gliclazide—type 2 diabetes mellitus	8.78e-05	0.00096	CcSEcCtD
Procainamide—Malaise—Ramipril—type 2 diabetes mellitus	8.74e-05	0.000955	CcSEcCtD
Procainamide—Lidocaine—CYP1A2—type 2 diabetes mellitus	8.72e-05	0.0333	CrCbGaD
Procainamide—CYP2D6—liver—type 2 diabetes mellitus	8.71e-05	0.00313	CbGeAlD
Procainamide—Hypotension—Losartan—type 2 diabetes mellitus	8.62e-05	0.000942	CcSEcCtD
Procainamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.56e-05	0.000935	CcSEcCtD
Procainamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.52e-05	0.000931	CcSEcCtD
Procainamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000928	CcSEcCtD
Procainamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.49e-05	0.000928	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.4e-05	0.000919	CcSEcCtD
Procainamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.4e-05	0.000918	CcSEcCtD
Procainamide—Convulsion—Ramipril—type 2 diabetes mellitus	8.39e-05	0.000918	CcSEcCtD
Procainamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.3e-05	0.000908	CcSEcCtD
Procainamide—Urticaria—Metformin—type 2 diabetes mellitus	8.25e-05	0.000902	CcSEcCtD
Procainamide—Myalgia—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000902	CcSEcCtD
Procainamide—Arthralgia—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000902	CcSEcCtD
Procainamide—Nausea—Glyburide—type 2 diabetes mellitus	8.21e-05	0.000898	CcSEcCtD
Procainamide—Abdominal pain—Metformin—type 2 diabetes mellitus	8.21e-05	0.000897	CcSEcCtD
Procainamide—Dizziness—Gliclazide—type 2 diabetes mellitus	8.21e-05	0.000897	CcSEcCtD
Procainamide—Asthenia—Valsartan—type 2 diabetes mellitus	8.18e-05	0.000894	CcSEcCtD
Procainamide—Discomfort—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000891	CcSEcCtD
Procainamide—Asthenia—Orlistat—type 2 diabetes mellitus	8.08e-05	0.000884	CcSEcCtD
Procainamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000883	CcSEcCtD
Procainamide—Pruritus—Valsartan—type 2 diabetes mellitus	8.07e-05	0.000882	CcSEcCtD
Procainamide—Decreased appetite—Losartan—type 2 diabetes mellitus	8.02e-05	0.000876	CcSEcCtD
Procainamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.01e-05	0.000876	CcSEcCtD
Procainamide—Confusional state—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000872	CcSEcCtD
Procainamide—Pruritus—Orlistat—type 2 diabetes mellitus	7.97e-05	0.000872	CcSEcCtD
Procainamide—Vomiting—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.000863	CcSEcCtD
Procainamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000853	CcSEcCtD
Procainamide—Urticaria—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000851	CcSEcCtD
Procainamide—Shock—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000851	CcSEcCtD
Procainamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000847	CcSEcCtD
Procainamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000847	CcSEcCtD
Procainamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000846	CcSEcCtD
Procainamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000843	CcSEcCtD
Procainamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.6e-05	0.000831	CcSEcCtD
Procainamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.54e-05	0.000824	CcSEcCtD
Procainamide—Dizziness—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000824	CcSEcCtD
Procainamide—Anorexia—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000824	CcSEcCtD
Procainamide—Dizziness—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000815	CcSEcCtD
Procainamide—Asthenia—Metformin—type 2 diabetes mellitus	7.45e-05	0.000815	CcSEcCtD
Procainamide—Hypotension—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000808	CcSEcCtD
Procainamide—Nausea—Gliclazide—type 2 diabetes mellitus	7.37e-05	0.000806	CcSEcCtD
Procainamide—Pruritus—Metformin—type 2 diabetes mellitus	7.35e-05	0.000803	CcSEcCtD
Procainamide—Urticaria—Losartan—type 2 diabetes mellitus	7.33e-05	0.000801	CcSEcCtD
Procainamide—Body temperature increased—Losartan—type 2 diabetes mellitus	7.29e-05	0.000797	CcSEcCtD
Procainamide—Abdominal pain—Losartan—type 2 diabetes mellitus	7.29e-05	0.000797	CcSEcCtD
Procainamide—Vomiting—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000793	CcSEcCtD
Procainamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000789	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000788	CcSEcCtD
Procainamide—Vomiting—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000783	CcSEcCtD
Procainamide—Diarrhoea—Metformin—type 2 diabetes mellitus	7.1e-05	0.000777	CcSEcCtD
Procainamide—Asthenia—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.000769	CcSEcCtD
Procainamide—Pruritus—Irbesartan—type 2 diabetes mellitus	6.93e-05	0.000758	CcSEcCtD
Procainamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000752	CcSEcCtD
Procainamide—Dizziness—Metformin—type 2 diabetes mellitus	6.87e-05	0.000751	CcSEcCtD
Procainamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.79e-05	0.000743	CcSEcCtD
Procainamide—Nausea—Valsartan—type 2 diabetes mellitus	6.77e-05	0.00074	CcSEcCtD
Procainamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000733	CcSEcCtD
Procainamide—Nausea—Orlistat—type 2 diabetes mellitus	6.69e-05	0.000732	CcSEcCtD
Procainamide—Asthenia—Losartan—type 2 diabetes mellitus	6.62e-05	0.000723	CcSEcCtD
Procainamide—Vomiting—Metformin—type 2 diabetes mellitus	6.6e-05	0.000722	CcSEcCtD
Procainamide—Pruritus—Losartan—type 2 diabetes mellitus	6.52e-05	0.000713	CcSEcCtD
Procainamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000712	CcSEcCtD
Procainamide—Dizziness—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000708	CcSEcCtD
Procainamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000707	CcSEcCtD
Procainamide—Diarrhoea—Losartan—type 2 diabetes mellitus	6.31e-05	0.00069	CcSEcCtD
Procainamide—Urticaria—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000687	CcSEcCtD
Procainamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000683	CcSEcCtD
Procainamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000683	CcSEcCtD
Procainamide—Vomiting—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000681	CcSEcCtD
Procainamide—Nausea—Metformin—type 2 diabetes mellitus	6.17e-05	0.000674	CcSEcCtD
Procainamide—Dizziness—Losartan—type 2 diabetes mellitus	6.1e-05	0.000667	CcSEcCtD
Procainamide—Probenecid—CYP3A4—type 2 diabetes mellitus	6e-05	0.0229	CrCbGaD
Procainamide—Vomiting—Losartan—type 2 diabetes mellitus	5.86e-05	0.000641	CcSEcCtD
Procainamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000637	CcSEcCtD
Procainamide—Nausea—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000636	CcSEcCtD
Procainamide—Lidocaine—CYP3A4—type 2 diabetes mellitus	5.77e-05	0.022	CrCbGaD
Procainamide—Asthenia—Ramipril—type 2 diabetes mellitus	5.67e-05	0.00062	CcSEcCtD
Procainamide—Pruritus—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000612	CcSEcCtD
Procainamide—Nausea—Losartan—type 2 diabetes mellitus	5.48e-05	0.000599	CcSEcCtD
Procainamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000592	CcSEcCtD
Procainamide—Probenecid—ALB—type 2 diabetes mellitus	5.24e-05	0.02	CrCbGaD
Procainamide—Dizziness—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000572	CcSEcCtD
Procainamide—Vomiting—Ramipril—type 2 diabetes mellitus	5.03e-05	0.00055	CcSEcCtD
Procainamide—Sunitinib—CYP3A4—type 2 diabetes mellitus	4.72e-05	0.018	CrCbGaD
Procainamide—Nausea—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000514	CcSEcCtD
Procainamide—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.6e-06	4.71e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.59e-06	4.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.59e-06	4.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.58e-06	4.68e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	3.55e-06	4.64e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	3.54e-06	4.63e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.54e-06	4.63e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.53e-06	4.61e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—LPL—type 2 diabetes mellitus	3.49e-06	4.56e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.48e-06	4.55e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.47e-06	4.54e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.47e-06	4.54e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.47e-06	4.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.46e-06	4.52e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.44e-06	4.5e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.44e-06	4.5e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	3.42e-06	4.47e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.42e-06	4.47e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	3.41e-06	4.46e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	3.4e-06	4.45e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.4e-06	4.45e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	3.4e-06	4.45e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.36e-06	4.39e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAT—type 2 diabetes mellitus	3.36e-06	4.39e-05	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	3.33e-06	4.36e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.32e-06	4.35e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CD36—type 2 diabetes mellitus	3.31e-06	4.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	3.3e-06	4.31e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.3e-06	4.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.28e-06	4.29e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	3.27e-06	4.28e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	3.26e-06	4.27e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOB—type 2 diabetes mellitus	3.26e-06	4.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.25e-06	4.24e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—type 2 diabetes mellitus	3.23e-06	4.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.23e-06	4.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.21e-06	4.19e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—type 2 diabetes mellitus	3.17e-06	4.15e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	3.17e-06	4.14e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.16e-06	4.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.15e-06	4.12e-05	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—type 2 diabetes mellitus	3.15e-06	4.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.15e-06	4.11e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	3.14e-06	4.1e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.13e-06	4.09e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—type 2 diabetes mellitus	3.11e-06	4.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.09e-06	4.04e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	3.08e-06	4.03e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	3.05e-06	3.99e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	3.05e-06	3.99e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.05e-06	3.99e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	3.04e-06	3.98e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.04e-06	3.97e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	3.03e-06	3.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.02e-06	3.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3e-06	3.92e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	3e-06	3.92e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—type 2 diabetes mellitus	2.98e-06	3.9e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD36—type 2 diabetes mellitus	2.96e-06	3.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.95e-06	3.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.95e-06	3.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.95e-06	3.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.95e-06	3.86e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	2.93e-06	3.83e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—type 2 diabetes mellitus	2.92e-06	3.82e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.92e-06	3.82e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	2.92e-06	3.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.91e-06	3.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.91e-06	3.81e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	2.91e-06	3.8e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—type 2 diabetes mellitus	2.91e-06	3.8e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	2.89e-06	3.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.87e-06	3.75e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	2.84e-06	3.72e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.84e-06	3.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.83e-06	3.7e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.83e-06	3.7e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.83e-06	3.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.83e-06	3.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.82e-06	3.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.82e-06	3.69e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	2.8e-06	3.66e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	2.79e-06	3.65e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.78e-06	3.64e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—type 2 diabetes mellitus	2.78e-06	3.64e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	2.78e-06	3.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.77e-06	3.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.76e-06	3.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.76e-06	3.61e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	2.75e-06	3.59e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.73e-06	3.56e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.72e-06	3.56e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	2.71e-06	3.55e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	2.71e-06	3.54e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—type 2 diabetes mellitus	2.66e-06	3.48e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.65e-06	3.47e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	2.64e-06	3.45e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.64e-06	3.45e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.63e-06	3.44e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	2.62e-06	3.42e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—type 2 diabetes mellitus	2.61e-06	3.41e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.61e-06	3.41e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	2.59e-06	3.39e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	2.58e-06	3.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.57e-06	3.36e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.56e-06	3.34e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	2.55e-06	3.33e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—type 2 diabetes mellitus	2.54e-06	3.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.53e-06	3.31e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.53e-06	3.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.52e-06	3.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.52e-06	3.3e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.5e-06	3.27e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—type 2 diabetes mellitus	2.5e-06	3.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.48e-06	3.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.47e-06	3.24e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	2.46e-06	3.22e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.45e-06	3.21e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	2.45e-06	3.21e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.43e-06	3.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.4e-06	3.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.4e-06	3.14e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	2.38e-06	3.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.36e-06	3.09e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.36e-06	3.08e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.34e-06	3.06e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.34e-06	3.06e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.34e-06	3.06e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	2.34e-06	3.06e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.33e-06	3.05e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.33e-06	3.05e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	2.33e-06	3.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.32e-06	3.03e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.32e-06	3.03e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	2.3e-06	3.01e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—type 2 diabetes mellitus	2.29e-06	2.99e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.29e-06	2.99e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	2.29e-06	2.99e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.27e-06	2.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.26e-06	2.96e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—type 2 diabetes mellitus	2.23e-06	2.91e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	2.21e-06	2.9e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.2e-06	2.87e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	2.19e-06	2.86e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.19e-06	2.86e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	2.18e-06	2.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.18e-06	2.84e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	2.17e-06	2.84e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.15e-06	2.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.15e-06	2.81e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	2.15e-06	2.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.14e-06	2.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.13e-06	2.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.11e-06	2.75e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.1e-06	2.75e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.1e-06	2.75e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.1e-06	2.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.07e-06	2.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.07e-06	2.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.06e-06	2.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.04e-06	2.67e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—type 2 diabetes mellitus	2.04e-06	2.67e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.04e-06	2.67e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.03e-06	2.65e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	2e-06	2.62e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2e-06	2.62e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.99e-06	2.6e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.98e-06	2.59e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.95e-06	2.55e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.95e-06	2.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.94e-06	2.54e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.92e-06	2.51e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.9e-06	2.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.9e-06	2.49e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.89e-06	2.47e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.86e-06	2.43e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.85e-06	2.42e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.85e-06	2.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.82e-06	2.39e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.82e-06	2.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.82e-06	2.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.82e-06	2.38e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-06	2.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.78e-06	2.33e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.74e-06	2.28e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.74e-06	2.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.7e-06	2.22e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.7e-06	2.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.7e-06	2.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.69e-06	2.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.67e-06	2.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.66e-06	2.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.66e-06	2.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.64e-06	2.15e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.63e-06	2.13e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.63e-06	2.13e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.6e-06	2.09e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.57e-06	2.05e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.57e-06	2.05e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.57e-06	2.05e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.56e-06	2.04e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.54e-06	2.02e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.5e-06	1.96e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.49e-06	1.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.48e-06	1.94e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.46e-06	1.91e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.43e-06	1.87e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.42e-06	1.85e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.4e-06	1.83e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.4e-06	1.82e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.4e-06	1.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.37e-06	1.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.37e-06	1.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.36e-06	1.78e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.36e-06	1.78e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.34e-06	1.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.3e-06	1.7e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.29e-06	1.68e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-06	1.67e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.26e-06	1.65e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.24e-06	1.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.63e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.22e-06	1.6e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.2e-06	1.57e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.2e-06	1.57e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	1.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.17e-06	1.53e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.07e-06	1.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.06e-06	1.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.05e-06	1.37e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	1.37e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	1.34e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-06	1.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.98e-07	1.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.87e-07	1.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.68e-07	1.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.39e-07	1.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.2e-07	1.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.98e-07	1.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.98e-07	1.17e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	8.98e-07	1.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.96e-07	1.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.22e-07	1.08e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.21e-07	1.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.06e-07	1.05e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	8.02e-07	1.05e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	7.47e-07	9.77e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.2e-07	8.1e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.72e-07	7.48e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.13e-07	5.4e-06	CbGpPWpGaD
